A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Examine the ability of Timunox (thymopentin) to reduce the amount and/or frequency of virus
isolation. Examine the ability of thymopentin to stimulate the immune system and alter the
clinical findings in patients infected with HIV who do not yet have AIDS.